There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Quote of the Day: Melinda French Gates states that societies move backward when men make decisions for women. Her words champion equality a...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

What is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...

This global recognition highlights the institute's excellence in research, education, and animal health services.

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...

The Group of Seven (G7) rich nations is set to agree on establishing a new program to distribute vaccines to developing countries at next w...

The agency said its expert vaccine group assessed the increasing data about booster doses and noted the waning of immune protection over ti...

Known as COVAX, the program was supposed to be a global powerhouse, a multibillion-dollar alliance of international health bodies and nonpr...

The design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...

The partnership’s first vertical solution, vaxyn8, leverages Freshworks Neo platform’s capabilities to bring to market an easily configurab...

India’s GDP contracted by 7.5% between July and September, compared to the same quarter a year before. Between April to June Indian economy...

While China wasn’t on the list, 38 governments are expected to sign up in the coming days, according to a statement Monday from Gavi, the V...

The company's 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to prevent pneumonia has been selected for immunisation program in certain ...

The Health Ministry recently announced that the PCV that can combat pneumonia, will be rolled out as part of the Universal Immunisation Pro...

New York-headquartered pharmaceutical giant is likely to leverage its latest European approval for multi-dose vials of pneumococcal vaccine...